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BrainIn the present study, we compared alkali-resistant BAX insertion into the outer mitochondrial membrane,
mitochondrial remodeling, mitochondrial membrane potential changes, and cytochrome c (Cyt c) release
from isolated brain mitochondria triggered by recombinant BAX oligomerized with 1% octyl glucoside
(BAXoligo) and by a combination of monomeric BAX (BAXmono) and caspase 8-cleaved C-terminal fragment of
recombinant BID (truncated BID, tcBID). We also examined whether the effects induced by BAXoligo or by
BAXmono activated with tcBID depended on induction of the mitochondrial permeability transition. The
results obtained in this study revealed that tcBID plus BAXmono produced BAX insertion and Cyt c release
without overt changes in mitochondrial morphology. On the contrary, treatment of mitochondria with
BAXoligo resulted in BAX insertion and Cyt c release, which were accompanied by gross distortion of
mitochondrial morphology. The effects of BAXoligo could be at least partially suppressed by mitochondrial
depolarization. The effects of tcBID plus BAXmono were insensitive to depolarization. BAXoligo produced
similar BAX insertion, mitochondrial remodeling, and Cyt c release in KCl- and in N-methyl-D-glucamine-
based incubation media indicating a non-essential role for K+ inﬂux into mitochondria in these processes. A
combination of cyclosporin A and ADP, inhibitors of the mitochondrial permeability transition, attenuated
Cyt c release, mitochondrial remodeling, and depolarization induced by BAXoligo, but failed to inﬂuence the
effects produced by tcBID plus BAXmono. Thus, our results suggest a signiﬁcant difference in the mechanisms
of the outer mitochondrial membrane permeabilization and Cyt c release induced by detergent-oligomerized
BAXoligo and by BAX activated with t
cBID.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The release of cytochrome c (Cyt c) and other apoptogenic
proteins located in the intermembrane space between the outer
(OMM) and the inner mitochondrial membranes (IMM) is pivotal for
execution of apoptosis [1]. Since mitochondrial apoptogenic proteins
are conﬁned within the intermembrane space, their release during
apoptosis requires permeabilization of the OMM. Permeabilization of
the OMM could result from the rupture of the OMM due toonomeric BAX oligomerized in
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ll rights reserved.mitochondrial swelling in the process called the mitochondrial
permeability transition (mPT) [2–5]. The precise molecular mechan-
isms of the mPT are still unclear [6,7], but it is known that Ca2+ inﬂux
into mitochondria is a major factor leading to the mPT [8,9]. Alter-
natively, OMM permeabilization could be due to interaction of pro-
apoptotic proteins such as BAX and BIDwith the OMM [10–12]. In this
case, the release of mitochondrial proteins might occur without overt
mitochondrial morphological changes via proteinaceous or lipidic
pores in the OMM [13,14]. However, there are several reports
indicating that the pro-apoptotic proteins BAX and BID could also
trigger mPT-like events leading to mitochondrial swelling and
the release of Cyt c perhaps associated with the rupture of the OMM
[15–17].
Both full-length BID and BAX monomers (BAXmono) are normally
located in the cytosol and remain inactive until apoptotic stimulus
triggers a cascade of apoptotic reactions [18–20]. Following apoptotic
stimulus, BID cleaved by caspase-8 (truncated BID, tBID) interacts
with BAXmono causing its oligomerization and insertion of the
oligomeric BAX in the OMM [21–23]. In addition, BAXmono can be
enforced to oligomerize in the presence of mild non-ionic detergents
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artiﬁcially oligomerized BAXoligo as well as a combination of
recombinant tBID and BAXmono is widely used to study the mechan-
isms of OMM permeabilization in experiments with isolated mito-
chondria [26–29]. While it is known that both BAXoligo and a
combination of tBID and BAXmono produce signiﬁcant Cyt c release
from brain mitochondria [17,28], it remains unknown whether the
mechanism of OMM permeabilization is the same in both cases.
In the present study, we examined Cyt c release and morphological
remodeling triggered by recombinant, artiﬁcially oligomerized BAXoligo
and by a combination of BAXmono and C-terminal fragment of
recombinant BID (tcBID) in isolated brain mitochondria. The resultsFig. 1. BAXoligo induced large-amplitude mitochondrial swelling sensitive to mitochond
incubation medium. In a–c, mitochondria were incubated in the KCl-based medium. In d–f,
added as indicated. In all panels, 30 µg/ml alamethicin was added at the end of the experimen
summary of the experiments in KCl- and NMDG-medium, respectively. In all experiments, t
swelling produced by BAXoligo was expressed as a percentage from the maximal alamethic
presence of 1 µM FCCP. Data are mean±SEM, N=4.obtained in this study revealed that BAXmono activated by tcBID
produced alkali-resistant BAX insertion and Cyt c release without
overt changes in mitochondrial morphology and independently from
Δψ. On the contrary, treatmentofmitochondriawithBAXoligo resulted in
BAX insertion and Cyt c release accompanied by gross distortion of
mitochondrial morphology. All these effects of BAXoligo were at least
partially suppressed by mitochondrial depolarization. The combination
of cyclosporin A and ADP, efﬁcacious inhibitors of the mPT in brain
mitochondria [17], attenuatedCyt c release,mitochondrial swelling, and
depolarization induced by BAXoligo, but failed to inﬂuence the effects
produced by tcBID plus BAXmono. Thus, our results demonstrate
signiﬁcant differences in the effects of artiﬁcially oligomerized BAXoligorial depolarization with FCCP in KCl- and in N-methyl-D-glucamine (NMDG)-based
mitochondria were incubated in NMDG-based medium. In a–f, 7.2 µg/ml BAXoligo was
ts to obtainmaximal swelling. In b and e, 1 µM FCCPwas added as indicated. In c and f, a
he amplitude of swelling produced by alamethicin was taken as 100% and amplitude of
in-induced swelling. *pb0.01 between the effect of BAXoligo alone and BAXoligo in the
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underlying the OMM permeabilization in these cases.2. Materials and methods
2.1. Recombinant proteins
Recombinant full-length BAX and active C-terminal fragment of
recombinant BID (tcBID), generated by cutting BID with caspase 8 and
subsequently separated from the N-terminal fragment and caspase,
were prepared as described earlier [30,31]. Monomeric full-length
BAX was oligomerized in the dialysis buffer containing 25 mMFig. 2. The electron micrographs of isolated brain mitochondria treated with BAXoligo with an
for 30 min at 37 °C in KCl- or NMDG-based medium, respectively. In a and d, mitochondria w
37 °Cwith 7.2 µg/ml BAXoligo. In c and f, mitochondria were pre-treatedwith 1 µM FCCP for 2
incubation medium during the experiment.HEPES–NaOH, pH 7.5, 1% (w/v) octyl glucoside, 0.2 mMdithiothreitol,
and 30% glycerol (v/v) as described previously [30].2.2. Isolation and puriﬁcation of brain mitochondria
Mitochondria from the brains of male Sprague–Dawley rats, 200–
250 g (Harlan, Indianapolis, IN, USA)were isolated inmannitol–sucrose
medium according to an IACUC approved protocol and puriﬁed on a
discontinuous Percoll gradient as described previously [5]. Mitochon-
drial protein wasmeasured by the Bradfordmethod [32] using BSA as a
standard. In all experiments with isolated mitochondria, the concen-
tration of mitochondrial protein in the chamber was 0.2 mg/ml.d without FCCP. In a–c and d–f, mitochondria were incubated under very gentle shaking
ere incubated without additions. In b and e, mitochondria were incubated for 30 min at
min, and then 7.2 µg/ml BAXoligo was added for the next 30 min. FCCP (1 µM)was in the
Fig. 3.Mitochondrial depolarization with FCCP inhibited cytochrome c release induced
by BAXoligo but did not inﬂuence cytochrome c release induced by alamethicin. In a,
mitochondria were incubated in KCl-based medium; in c, mitochondria were incubated
in NMDG-based medium. In a and c where indicated, mitochondria were treated with
7.2 µg/ml BAXoligo for 30 min at 37 °C under very gentle shaking. 0.01% octyl glucoside
was used as a vehicle. Where indicated, prior to addition of BAXoligo mitochondria were
pre-treated with 1 µM FCCP for 2 min and FCCP (1 µM) was kept in the incubation
medium during the experiment. To completely release cytochrome c (Cyt c), 30 µg/ml
alamethicin was applied tomitochondria for 30 min at 37 °C. COX IV immunoblots were
used as a control for equal loading. Panels b and d show summaries of cytochrome c
release in different conditions. In all cases, cytochrome c release with alamethicin
(Alam) was taken as 100%. In b, *pb0.001 between the BAXoligo-induced cytochrome c
release with and without 1 µM FCCP; in d, *pb0.05 between the BAXoligo-induced
cytochrome c release with and without 1 µM FCCP. Data are mean±SEM, N=5.
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in the incubation medium
Mitochondrial swelling was evaluated by monitoring the light
scattering of mitochondrial suspension under 90° to the axis of the
photodetector at 525 nm in a 0.4-ml cuvette under continuous stirring
using a PerkinElmer LS-55 luminescence spectrometer. The incubation
medium contained 125 mM KCl or 125 mM N-methyl-D-glucamine
(NMDG), 10 mM HEPES, pH 7.4, 0.5 mM MgCl2, 3 mM KH2PO4, 0.1%
bovine serum albumin (free from fatty acids), 3 mM succinate, 3 mM
glutamate, and 10 µM EGTA unless stated otherwise. In the case of
NMDG-based medium, all precautions were taken to avoid K+ in the
medium. KH2PO4was substituted for H3PO4, and pH in all solutionswas
adjusted with Tris–HCl. Alternatively, mitochondrial swelling was
evaluated simultaneously with Δψ by following changes in light
scattering of the mitochondrial suspension at 525 nm with an incident
beam under 180° in a 0.3 ml chamber at 37 °C and continuous stirring.
Δψ was monitored by following the distribution of tetraphenylpho-
sphoniumcation (TPP+) between the externalmedium(initially 1.8 µM
TPP+–Cl) and themitochondrialmatrixwith a TPP+-sensitive electrode
[33] in the standard KCl-based incubation medium. A decline in the
external TPP+ concentration ([TPP+]o) corresponded to mitochondrial
polarization, while a rise in the [TPP+]o in themedium corresponded to
depolarization. Ca2+ concentration in the incubation medium was
assessed with a miniature Ca2+-selective electrode in a 0.3 ml chamber
at 37 °C and continuous stirring. In all ﬁgures, all data traces shown are
representative of at least three separate experiments.
2.4. Transmission electron microscopy
Electron microscopy of isolated brain mitochondria was performed
as described previously [17,34]. Brieﬂy,mitochondriawere incubated in
the standard 125 mM KCl- or 125 mM NMDG-based medium with or
without recombinant BAXoligo (7.2 µg/ml) or tcBID (0.33 µg/ml) or a
combinationof tcBID (0.33 µg/ml) andmonomeric BAX(BAXmono, 1 µg/
ml) for 30 min at 37 °C prior to ﬁxation in 2% paraformaldehyde and 2%
glutaraldehyde in 0.05 M phosphate buffer in the same incubation
medium at room temperature for 15 min. Electron micrographs were
taken using a Tecnai G12 BioTwin electron microscope (FEI, Hillsboro,
OR) equipped with an AMT 2.6×2.6 K digital CCD camera.
2.5. BAX insertion
Alkali-resistant BAX insertion into the OMM was assessed as
described earlier [35]. Brieﬂy, mitochondria treated with either
BAXoligo or tcBID or a combination of tcBID and BAXmono at 37 °C for
30 min were pelleted at 15,800 g for 5 min, and supernatant was used
for the cytochrome c release measurements. Mitochondrial pellets
were re-suspended in 0.2 ml of 0.1 Na2CO3, pH 11.5, and incubated for
20 min on ice. Samples were centrifuged for 25 min at 100,000 ×g in a
Sorvall Ultra Pro® 80 ultracentrifuge. The pellets were solubilized
using 2% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesul-
fonate (CHAPS) and analyzed by western blotting against BAX and
cytochrome oxidase subunit IV (COX IV, loading control).
2.6. Immunoblotting
The release of cytochrome c from isolated brain mitochondria was
assessed as described previously [17] using western blotting in super-
nates obtained through incubation of mitochondria in the 125 mMKCl-
or 125 mM NMDG-based incubation medium for 30 min at 37 °C. For
electrophoresis, we used 4–12% Bis–Tris MOPS gels (Invitrogen,
Carlsbad, CA). Western blotting was performed as previously described
[28]. The release of cytochrome c from mitochondria treated with
alamethicin (30 µg/ml)was used as a control formaximal cytochrome c
release. COX IVwas used as a loading control for the pellet samples. COX
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1:5000 (Invitrogen, Carlsbad, CA). Following electrophoresis, proteins
were transferred to Hybond™-ECL™ nitrocellulose membrane (Amer-
sham Biosciences, Piscataway, NJ), and blots were incubated with
primary mouse anti-cytochrome c antibody (7H8.2C12, PharMingen,
SanDiego, CA) at 1:1000 dilution for an hour at room temperature in 5%
non-fatmilk, phosphate-buffered saline, pH 7.2, and0.15%TritonX-100.
In the BAXoligo insertion experiments, BAX was detected with rabbit
anti-BAX antibody (Upstate, Lake Placid, NY) used at 1:2000 dilution.
Blots were developed using goat anti-rabbit and anti-mouse IgG
(1:20,000) coupled to horseradish peroxidase (Jackson ImmunoRe-
search Laboratories, West Grove, PA) and Supersignal West chemilu-
minescent reagents (Pierce, Rockford, IL). Molecular weight marker
SeeBlue® Plus 2 Standards (5 µl), (Invitrogen, Carlsbad, CA)was used to
determine molecular weights of the bands. Band intensities were
evaluated using ImageJ software (http://rsb.info.nih.gov/ij/).Fig. 4. BAXoligo solution did not contain detectable amounts of Ca2+. BAXoligo induced sim
attenuated cytochrome c release induced by BAXoligo regardless of EGTA concentration. In a, a
EGTA, 10.8 µg/ml BAXoligo or 25 µM Ca2+ was added. In b, cytochrome c release from brain m
media supplemented either with 10 µM (standard incubation medium, EGTA -) or with 1 m
Cytochrome c release with alamethicin (Alam) was taken as 100%. In d, 1 µM FCCP decrease
incubation media with 10 µM (EGTA -) or with 1 mM EGTA(EGTA +). In e, a summary of cy
was taken as 100%. *pb0.01 between the BAXoligo-induced cytochrome c release with and wi2.7. Statistics
Statistical analyses of experimental data consisted of a one-way
analysis of variance followed by Bonferroni's post hoc test (GraphPad
Prism, version 4.0; GraphPad Software, San Diego, CA). The data
represent the mean±SEM of at least three separate, independent
experiments.
3. Results
In our previous paper, we found that BAXoligo caused Cyt c release
accompanied by strong mitochondrial swelling [17]. We conﬁrmed our
previous observations in the present study. Addition of BAXoligo to
mitochondria resulted in large-amplitude mitochondrial swelling as
judged by light scattering assay (Fig. 1a). In these experiments, the
antibiotic alamethicin was used to produce maximal mitochondrialilar cytochrome c release in the incubation media with 10 µM or 1 mM EGTA. FCCP
representative trace obtained with a Ca2+-sensitive electrode. Where indicated, 10 µM
itochondria induced by 10.8 µg/ml BAXoligo or 30 µg/ml alamethicin in the incubation
M EGTA(EGTA +). In c, a summary of cytochrome c release under different conditions.
d cytochrome c release from brain mitochondria induced by 10.8 µg/ml BAXoligo in the
tochrome c release under different conditions. Here, cytochrome c release with BAXoligo
thout 1 µM FCCP. In all these experiments, 0.015% octyl glucoside was used as a vehicle.
Fig. 5.Mitochondrial depolarizationwith FCCP inhibited alkali-resistantBAX insertion into
the outer membrane. In a, mitochondria were incubated in KCl-based medium; in c,
mitochondria were incubated in NMDG-based medium. In a and b, mitochondria were
incubatedunder verygentle shaking for 30min at 37 °Cwith7.2 µg/ml BAXoligo. Then, BAX
insertion was evaluated as described in Materials and methods. Where indicated,
mitochondria were pre-treated with 1 µM FCCP for 2 min and then incubated with
7.2 µg/ml BAXoligo for 30 min at 37 °C. COX IV immunoblots were used as a control for
equal loading. In c, a summary of BAX insertion experimentswith andwithout 1 µM FCCP.
In both KCl- and NMDG-medium, BAX insertion without FCCP was taken as 100%.
*pb0.001 between the BAX insertion with and without 1 µM FCCP. Data are mean±SEM,
N=5.
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swelling as 100%, we quantitatively evaluated mitochondrial swelling
induced by BAXoligo. Recently, Eliseev et al. reported that in isolated liver
mitochondria tBID stimulated K+ inﬂux accompanied by osmotically
obliged water leading to mitochondrial swelling, the rupture of the
OMM, andCyt c release [36]. In our study,we addressedwhether BAXoligo
could also cause K+ inﬂux into isolated brain mitochondria leading to
mitochondrial swelling and Cyt c release. Based on the assumption that
mitochondrialmembranepotential (Δψ) is thedriving force forK+ inﬂux
[37], we depolarizedmitochondria with FCCP, a potent protonophore, to
assesswhether BAXoligo-inducedmitochondrial swelling occurred due to
K+ inﬂux into mitochondria. In our experiments 1 µM FCCP caused
complete mitochondrial depolarization as judged by tetraphenylpho-
sphoniumcation (TPP+) re-distribution in the experimentswith a TPP+-
sensitive electrode (not shown).Mitochondrial depolarizationwith FCCP
resulted in a slight increase in light scattering of mitochondrial
suspension, suggesting mitochondrial contraction (Fig. 1b). This could
be due to an imbalance of K+ efﬂux and inﬂux in mitochondria [37].
BAXoligo added after FCCP produced much smaller changes in light
scattering of mitochondrial suspension suggesting a decreased ampli-
tude of mitochondrial swelling, or a diminished subpopulation of
mitochondria experiencing swelling, or both (Fig. 1b). Overall, this
suggested that K+ inﬂux could be the mechanism of BAXoligo-induced
swelling. However, BAXoligo also induced large-amplitudemitochondrial
swelling in K+-free incubation medium where K+ was substituted for a
large organic cation N-methyl-D-glucamine (NMDG) (Fig. 1d). This
strongly argued against K+ inﬂux into mitochondria as a mechanism of
BAXoligo-induced mitochondrial swelling. Similarly to KCl-based medi-
um, in NMDG-medium, mitochondrial depolarization decreased BAX-
oligo-induced swelling (Fig. 1e). Fig. 1c and f summarize the results
obtained in light scattering assay with BAXoligo and FCCP in KCl- and
NMDG-based incubation media, respectively.
While the light scattering assay provides a valuable tool for express-
analysis of morphological changes in the entire mitochondrial popula-
tion, transmission electron microscopy (TEM) helps to visualize
morphological changes in individual mitochondria and corroborate
the results obtained in light scattering assay. Fig. 2 illustrates
mitochondrial remodeling following application of BAXoligo in the
absenceand in thepresenceof FCCP inKCl- (Fig. 2a–c) andNMDG-based
medium(Fig. 2d–f), respectively. The inserts in the upper right corner of
each panel demonstrate a representative type of mitochondrial
morphology for the particular experimental conditions under larger
magniﬁcation. Prior to BAXoligo addition, mitochondria incubated in
both KCl- and NMDG-medium were in condensed state (Fig. 2a and d),
typical for isolated brain mitochondria [17,27,28]. BAXoligo caused
signiﬁcant mitochondrial remodeling that could be deﬁned as a large-
amplitude swelling. In both KCl- and NMDG-medium, the majority of
mitochondria appeared to have grossly distortedmorphology following
30min of incubation with BAXoligo (Fig. 2b and e). Depolarization with
FCCP inhibited mitochondrial remodeling, presumably stopping mito-
chondrial morphological changes at an early stage characterized by the
appearance of dark circular structures in the matrix which we
tentatively deﬁne as tubular cristae (Fig. 2c and f). Previously, we
found similar inhibition of BAXoligo-induced mitochondrial remodeling
evokedby a combinationof cyclosporinAandADP, inhibitors of themPT
[17]. Similar changes in the appearance of mitochondrial cristae in
mouse liver mitochondria treated with tBID were reported earlier [38].
In this study, treatment of isolated mouse liver mitochondria with
recombinant tBID resulted in the appearance of the circular, electron-
dense matrix structures, apparently cristae which, depending on the
orientation of the thin section, could be assembled to look like an
“intestinal” or “sausage-shaped” electron-dense region.
Thus, TEMconﬁrmed signiﬁcantmorphological changes in individual
mitochondria treated with BAXoligo. In addition, TEM revealed a
transition to the tubular conﬁguration ofmitochondrial cristae following
combined application of FCCP and BAXoligo.In our previous paper, we showed a correlation between the extent
of mitochondrial swelling and the BAXoligo-induced Cyt c release [17].
Since FCCP inhibited BAXoligo-induced mitochondrial swelling, in the
following experiments, we addressed the question whether mitochon-
drial depolarization diminishes BAXoligo-induced Cyt c release. Prior to
our experiments we did not know whether mitochondrial depolariza-
tionwould inﬂuence BAXoligo-induced Cyt c release, or if it did, in which
direction. Therefore, we intentionally used a sub-optimal concentration
of BAXoligo (7.2 µg/ml) to provide room for a possible increase in Cyt c
release following BAXoligo application to depolarized mitochondria. The
incubation of naïve mitochondria without additions or with a vehicle
(0.01% octyl glucoside) for 30min at 37 °C produced negligible Cyt c
release (Fig. 3). Addition of BAXoligo in both KCl- and NMDG-medium
caused a signiﬁcant Cyt c release that could be attenuated, but not
completelyprevented, bymitochondrial depolarizationwith1 µMFCCP.
Alamethicin produced complete Cyt c release that was insensitive to
mitochondrial depolarization. Thus, the FCCP-induced decrease in
BAXoligo-triggered mitochondrial swelling correlated with the dimin-
ished Cyt c release in depolarized mitochondria regardless of the
composition of the incubation medium.
To test whether BAXoligo-induced Cyt c release and mitochondrial
swelling could be due to Ca2+ contamination in the BAXoligo stock
solution, we measured Ca2+ in the incubation medium following
BAXoligo addition. Fig. 4a shows that adding 10.8 µg/ml BAXoligo, the
maximal BAXoligo concentration used in our experiments, failed to
change the Ca2+ concentration in the medium. On the other hand,
addition of Ca2+ was easily detected. Thus, it is highly unlikely that the
effects of BAXoligo inourexperimentsweredue toCa2+contamination in
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we assessed Cyt c release induced by 10.8 µg/ml BAXoligo in the
incubation medium supplemented with 1 mM EGTA to ensure the lack
of residual Ca2+. Similar to alamethicin, BAXoligo at this concentration
produced complete Cyt c release within 30 min regardless of the
presence of 1 mM EGTA (Fig. 4b,c). Likewise, FCCP attenuated Cyt c
release induced by 10.8 µg/ml BAXoligo regardless of the presence of
1 mMEGTA(Fig. 4d,e). Thus, the effects of BAXoligowere not due to Ca2+
contamination in the BAXoligo stock solution, and depolarization could
attenuate BAXoligo-induced Cyt c release even in the presence of 1 mM
EGTA.
The inhibition of mitochondrial remodeling and the decrease in Cyt c
release from BAXoligo-treated depolarized mitochondria could be due to
hindered BAXoligo insertion into the OMM. To test this hypothesis, we
evaluated alkali-resistant incorporation of BAXoligo into the OMM inFig. 6. Neither tcBID nor monomeric BAX nor their combination induced mitochondrial remo
obtained in light scattering assay with isolated brain mitochondria. Where indicated 0.33 µg/
c–e, electronmicrographs of isolated brain mitochondria without treatment (c), after 30 min
tcBID plus 1 µg/ml BAXmono (e). In these experiments, mitochondria were incubated in KCpolarized versus depolarized mitochondria. In both KCl- and NMDG-
medium, we found a signiﬁcant decrease in alkali-resistant BAXoligo
insertion in the OMM of depolarized mitochondria (Fig. 5). Of note, the
amount of endogenous BAX in isolated brain mitochondria was below
the detection limit of western blotting. Thus, the decrease in BAXoligo-
inducedmitochondrial remodeling and Cyt c release could be due to the
decrease inBAXoligo insertion into theOMMofdepolarizedmitochondria.
In contrast to BAXoligo, neither tcBID nor BAXmono nor their
combination caused mitochondrial swelling monitored by following
light scattering of mitochondrial suspension (Fig. 6a,b). TEM conﬁrmed
this conclusion. Neither tcBID alone nor a combination of tcBID and
BAXmono caused mitochondrial remodeling of individual organelles
(Fig. 6c–e). tcBID alone produced small but statistically signiﬁcant Cyt c
release thatwas not sensitive tomitochondrial depolarization (Fig. 7a,b).
On the other hand, mitochondrial depolarizationwith FCCP caused Cyt cdeling in isolated brain mitochondria. In a and b, the representative experimental traces
ml tcBID, 1 µg/ml monomeric BAX (BAXmono) and 30 µg/ml alamethicin were added. In
of incubation with 0.33 µg/ml tcBID (d), and after 30 min of incubation with 0.33 µg/ml
l-based medium at 37 °C.
Fig. 7. Neither cytochrome c release induced by tcBID and by a combination of tcBID
with monomeric BAX nor alkali-resistant BAX insertion appeared to be sensitive to
mitochondrial depolarization. In a, cytochrome c (Cyt c) release induced by 0.33 µg/ml
tcBID and a combination of 0.33 µg/ml tcBID and 1 µg/ml monomeric BAX (BAXmono)
with and without 1 µM FCCP. In these experiments, mitochondria were incubated in
KCl-based medium at 37 °C. To completely release cytochrome c, 30 µg/ml alamethicin
was applied to mitochondria for 30 min at 37 °C. COX IV immunoblots were used as a
control for equal loading. Panel b shows a summary of cytochrome c release under
different conditions. The cytochrome c release with alamethicin (Alam) was taken as
100%. Data are mean±SEM, N=5. In c, alkali-resistant BAX insertion in the outer
mitochondrial membrane with and without mitochondrial depolarization with 1 µM
FCCP. Mitochondria were incubated for 30 min at 37 °Cwith 0.33 µg/ml tcBID and 1 µg/
ml BAXmono. Then, BAX insertion was evaluated as described in Materials and methods.
Where indicated, mitochondria were pre-treated with 1 µM FCCP for 2min and then
incubated with tcBID and BAXmono for 30min at 37 °C. COX IV immunoblots were used
as a control for equal loading.
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and BAXmono resulted in a complete Cyt c release comparable with the
alamethicin-induced Cyt c release (Fig. 6a,b). Aswith tcBID alone, theCyt
c release induced by a combination of tcBID andBAXmonowas insensitive
tomitochondrial depolarization. The alkali-resistant BAX insertion in the
OMM following addition of tcBID plus BAXmono was depolarization-
insensitive as well (Fig. 7c). Thus, in contrast to BAXoligo, tcBID plus
BAXmono-induced alkali-resistant BAX insertion into the OMM and Cyt c
release appeared to be independent from mitochondrial membrane
potential.
Finally, we compared the effects of BAXoligo and a combination of
tcBID and BAXmono in regard to their sensitivity to the inhibitors of the
mPT (Fig. 8). In these experiments we measured Cyt c release (Fig. 8a)
and, in addition, we monitored mitochondrial swelling following light
scattering of mitochondrial suspension and mitochondrial membrane
potential (Δψ) following the distribution of TPP+with a TPP+-sensitive
electrode (Fig. 8b–e). Mitochondrial swelling and Δψ were monitored
simultaneously. BAXoligo caused abrupt depolarization and pronounced
mitochondrial swelling (Fig. 8b) while neither tcBID nor BAXmono
resulted inmitochondrial swelling but produced gradual depolarization(Fig. 8d). In the latter case, we used Ca2+ (150 µM) as a positive control
to induce the mPT accompanied by mitochondrial swelling and
sustained depolarization. The combination of cyclosporin A (CsA) and
ADP (in the presence of 1 µM oligomycin to prevent ADP phosphory-
lation), efﬁcacious inhibitors of the mPT in brain mitochondria [17],
attenuated Cyt c release, mitochondrial swelling, and depolarization of
the organelles induced by BAXoligo (Fig. 8a,c) but failed to inﬂuence the
effects produced by tcBID plus BAXmono (Fig. 8a,e). This suggested that
the mPT was involved in the effects caused by BAXoligo but not in the
effects produced by tcBID plus BAXmono. Of note, CsA and ADPprevented
Ca2+-induced swelling and sustained depolarization (Fig. 8e). Under
these conditions, the transient depolarization might be due to Ca2+
uptake by mitochondria whereas an increase in light scattering might
reﬂect formation of calcium-phosphate precipitate in themitochondrial
matrix [39]. Thus, taken together, our results argued strongly in favor of
different mechanisms of OMM permeabilization by artiﬁcially oligo-
merized BAXoligo and by monomeric BAX activated by tcBID.
4. Discussion
In the present study, we investigated the mechanisms of the OMM
permeabilizationbypro-apoptotic proteins BAXoligo, tcBID, andBAXmono.
We clearly demonstrated that (i) BAXoligo-induced Cyt c release could be
inhibited by mitochondrial depolarization; (ii) BAXoligo-induced mito-
chondrial swelling and Cyt c release did not depend on K+ inﬂux into
mitochondria; and (iii) BAXoligo effects but not the effects of tcBID plus
BAXmono could be inhibited by inhibitors of the mitochondrial
permeability transition. These data and our results published previously
[17,27,28] strongly suggest that themechanismsof Cyt c release induced
by BAXoligo and by a combination of tcBID plus BAXmono are most likely
different.
In our experiments, we found that mitochondrial depolarization
with FCCP attenuated mitochondrial remodeling and Cyt c release
induced by BAXoligo. While the mechanisms of BAXoligo-induced
mitochondrial remodeling and its inhibition by FCCP remain obscure,
the inhibition of Cyt c release most likely was due to a decrease in BAX
insertion into the OMM. On the other hand, neither BAX insertion nor
Cyt c release induced by a combination of BAXmono and tcBID was
affected by mitochondrial depolarization. Moreover, in contrast to
BAXoligo, neither tcBID nor its combination with BAXmono altered
mitochondrial morphology. Inhibition of the mPT by CsA and ADP
attenuated BAXoligo-induced Cyt c release, mitochondrial swelling, and
depolarization but failed to inﬂuence the effects of tcBID and BAXmono.
Thus, the main ﬁnding in our study is that OMM permeabilization
induced by artiﬁcially oligomerized BAXoligo signiﬁcantly differs from
the permeabilization induced by monomeric BAXmono activated by
tcBID. Our conclusion is consistent with earlier observations that
channels formed by artiﬁcially oligomerized BAXoligo produced much
larger conductance in the planar lipid membranes than BAXmono
activated in the presence of caspase 8-cleaved BID [40].
One possible explanation for the difference seenwith the detergent-
oligomerized BAXoligo compared to the BAX oligomerized with tcBID
might be that the natural BAX channel is composed not only of BAX, but
it contains additional proteins [35].When oligomeric BAX isolated from
mitochondria of apoptotic cells was compared to the detergent-
oligomerized BAXoligo, a difference in the molecular weights of the
oligomers on SDS-PAGEwas observed and not all bands correlatedwith
molecular weights of BAX multimers, suggesting that there are
additional components associated with BAX in the apoptotic cell [41].
Thus, the effects of detergent-oligomerized recombinant BAXoligo
observed in in vitro experiments might differ from the effects of BAX
activated in its natural intracellular environment. Nevertheless, it iswell
established and widely accepted that BAXmono artiﬁcially oligomerized
with a mild, non-ionic detergent octyl glucoside represents a valuable
experimental tool that allows investigation of the intimatemolecular re-
arrangements of BAX and its consequences for the barrier properties of
Fig. 8. Cyclosporin A and ADP, inhibitors of the mitochondrial permeability transition, suppressed cytochrome c release, mitochondrial swelling, and depolarization of the organelles
induced by BAXoligo but not by a combination of tcBID and BAXmono. In a, 1 µM cyclosporin A (CsA), 100 µM ADP (plus 1 µM oligomycin to prevent ADP phosphorylation), 10.8 µg/ml
BAXoligo, 1 µg/ml BAXmono, and 1 µg/ml tcBID were added to mitochondria for 30 min at 37 °C as indicated. COX IV immunoblots were used as a control for equal loading. In b–e, the
upper traces show changes in light scattering indicative of mitochondrial remodeling, whereas the lower traces show changes in TPP+ concentration in the incubation medium
reﬂecting changes inΔψ. In b, 7.2 µg/ml BAXoligo was added as indicated. In c and e, 1 µM CsA and 100 µM ADP (plus 1 µM oligomycin) were added to the incubation medium prior to
mitochondria. 7.2 µg/ml BAXoligo was added as indicated. In d and e, 1 µg/ml tcBID, 1 µg/ml BAXmono, and 150 µM Ca2+ were added as indicated.
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re-arrangement of BAX and its subsequent oligomerization simulate the
key processes of BAX activation that take place in the cell following
apoptotic stimuli. At the same time, our data indicate that tcBID
signiﬁcantly exceeds octyl glucoside in its ability to activate BAXmono.
However, tcBID in addition to BAX might also activate BAK, a normal
constituent of the OMM [23,42]. Thus, the detergent-induced activation
of BAXmightbemore selective, and thereforemore beneﬁcial, in studies
of the mechanisms of BAX-induced OMM permeabilization. Yet, the
differences in the effects of detergent-oligomerized BAXoligo and
BAXmono activated by tcBID demonstrated in the present study have to
be kept in mind.
Another interesting observation made in our experiments is that
BAXoligo permeabilizes theOMMin aΔψ-dependentmanner in parallel
with mPT induction while a combination of BAXmono plus tcBID
permeabilizes the OMM in a Δψ-independent manner without mPT
induction. The reason for such a difference is not yet clear. However, it
is noteworthy that the concentration of BAXoligo required for complete
Cyt c release was 10 times higher [17] than the concentration of tcBID-activated BAXmono. A similar difference in the mechanisms of OMM
permeabilization was reported recently for low and high concentra-
tions of tBID [43]. At low concentrations, tBID permeabilized the OMM
without mPT induction, whereas at high concentrations tBID permea-
bilized the OMM in parallel with induction of the mPT. The authors
proposed that at high concentrations tBID causes cardiolipin transfer
from the IMM to the OMM. This could cause depletion of cardiolipin in
the IMM, destabilizing the adenine nucleotide translocase (ANT) that
might lead to conversion of the ANT into the mPT pore [43]. Indeed,
interaction of tBID with cardiolipin was shown to destabilize the ANT
[44]. BAXoligo also stimulates transbilayer transfer of lipids including
cardiolipin [45]. Therefore, it is possible that a mechanism similar to
those proposed to explain the effect of high concentration of tBID [43]
could be accountable in our experiments for BAXoligo-induced mPT in
brain mitochondria. However, whether such concentrations of
activated tBID or oligomerized BAX could be generated in the
apoptotic cell and whether such a scenario could take place in situ is
not yet clear. Regardless of the mechanism of OMM permeabilization,
our ﬁndings strongly suggest the difference between artiﬁcially
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ability to induce the mPT and permeabilize the OMM.
The inhibition of BAX insertion and Cyt c release induced by
mitochondrial depolarization is another key observation made in the
present study. The inhibition of BAXoligo-induced Cyt c release from
depolarized mitochondria has been reported previously. Recently, the
release of Cyt c and Smac/DIABLO induced by BAXoligo in non-
energized (depolarized) mitochondria from BAX/BAK double knock-
out mouse embryonic ﬁbroblasts was found to be signiﬁcantly
diminished in comparison with the protein release from energized
(polarized) mitochondria [29]. Interestingly, in contrast to Cyt c,
Smac/DIABLO is not electrostatically attached to cardiolipin in the
IMM [46] and does not require detachment from the OMM due to
cardiolipin oxidation. Nevertheless, the release of Smac/DIABLO was
also signiﬁcantly decreased in de-energized (depolarized) mitochon-
dria [29] suggesting an essential role of Δψ in the OMM permeabiliza-
tion by BAXoligo. In another study, investigators showed that the ability
of yeast mitochondria to respire is a key determinant of BAX toxicity
[47]. Mutations that yield respiration incompetent yeast strains (and,
obviously, with depolarized mitochondria) resulted in resistance to
BAX toxicity. Pucci et al. [48] presented data indicating that
mitochondrial depolarization inhibited BAX translocation to mito-
chondria in HeLa cells treated with TNF [48]. Correspondingly, Cyt c
release was strongly attenuated in cells with depolarized mitochon-
dria. In another study with mitochondria derived from HeLa cells,
treatment with phospholipase A2 (PLA2), which led to phosphatidyl-
ethanolamine and cardiolipin hydrolysis, hindered BAX insertion in
the OMM [49]. The authors proposed that the changes in membrane
properties due to hydrolysis of phospholipids might control the
process of BAX insertion in the OMM. However, treatments with PLA2
also resulted in accumulation of free fatty acids [49], which are natural
protonophores that depolarize mitochondria [50]. Thus, it seems
conceivable that mitochondrial depolarization due to FFA accumula-
tion contributed to PLA2-induced inhibition of BAX insertion in
mitochondria from HeLa cells. The mechanisms of depolarization-
induced inhibition of BAXoligo insertion into the OMM and BAXoligo-
induced Cyt c release remain unclear. However, it is obvious that in
contrast to BAXoligo, BAX insertion and Cyt c release induced by a
BAXmono activated by tcBID do not depend on Δψ. tcBID-induced
release of Cyt c was also Δψ-independent in our experiments. This is
consistent with the earlier ﬁndings that mitochondrial depolarization
with CCCP did not inhibit tBID-induced Cyt c release from isolated
heart mitochondria [51]. Thus, dependence on Δψ is another distinct
feature that differentiates the effects of BAXoligo from the effects of
BAXmono activated by tcBID. This conclusion once again emphasizes the
likelihood that different mechanisms underlie the effects of BAXoligo
and the effects of tcBID or its combination with BAXmono on the barrier
properties of the OMM.
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